BeStock  
Markets › Compare › ROL vs NBIX

ROL vs NBIX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ROL · Rollins$30.14 ▲ 0.07%
NBIX · Neurocrine Biosciences$142.63 ▲ 0.56%

Head to head

MetricROLNBIX
Price$30.14$142.63
Change today▲ 0.07%▲ 0.56%
Market cap$14.50B$14.50B
Return, 3 months––
Return, year to date––
Return, 1 year––
P/E (TTM)27.420.9
P/B10.13.9
P/E percentile vs own 5y––
Dividend yield2.37%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+38.8%+47.2%
Analyst buy share38%88%
RSI (14)––
30-day volatility––
Max drawdown, 1 year––
Trend read––
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ROL is the largest of the group by market value.
  • NBIX carries the lowest trailing P/E.

Go deeper

Scroll to Top